Statins in the prevention of perioperative cardiovascular complications

被引:7
|
作者
Schouten, Olaf [1 ]
Poldermans, Don [1 ]
机构
[1] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands
关键词
cardiovascular complications; perioperative; statins; vulnerable plaque;
D O I
10.1097/00001503-200502000-00009
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose of review This is a review of recent experimental and clinical evidence for the use of perioperative statins to reduce cardiovascular complications. Recent findings Clinical trials have demonstrated an improved survival of statin users in the perioperative period. This beneficial effect of statins is ascribed to the non-lipid lowering effect to stabilize vulnerable plaques, thereby preventing myocardial ischaemia and infarction. The proposed mechanism of this cardioprotective effect is by the anti-inflammatory properties of statins. The fear of adverse perioperative effects of statin use, i.e. rhabdomyolysis, has not been confirmed in clinical studies. Summary The anti-inflammatory properties of statins appear to have an important effect on coronary plaque stabilization in the perioperative setting, resulting in a reduction in perioperative cardiovascular complications.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [21] Statins in the primary prevention of cardiovascular disease
    Željko Reiner
    Nature Reviews Cardiology, 2013, 10 : 453 - 464
  • [22] Statins for the primary prevention of cardiovascular disease
    Taylor, Fiona
    Ward, Kirsten
    Moore, Theresa H. M.
    Burke, Margaret
    Smith, George Davey
    Casas, Juan-Pablo
    Ebrahim, Shah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [23] Statins are equivalent for cardiovascular disease prevention
    Zhou, Z
    Rahme, E
    Pilote, L
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (05) : 472 - 472
  • [24] Statins for primary prevention of cardiovascular disease
    Byrne, Paula
    Cullinan, John
    Smith, Susan M.
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [25] Statins for primary prevention of cardiovascular disease
    Otto, Catherine M.
    HEART, 2017, 103 (07) : 477 - 478
  • [26] Statins and the primary prevention of cardiovascular events
    Clearfield M.
    Current Atherosclerosis Reports, 2006, 8 (5) : 390 - 396
  • [27] Statins for primary cardiovascular prevention in the elderly
    Juan PedroBotet
    Elisenda Climent
    Juan J Chillaron
    Rocio Toro
    David Benaiges
    Juana A FloresLe Roux
    Journal of Geriatric Cardiology, 2015, 12 (04) : 431 - 438
  • [28] Statins for the primary prevention of cardiovascular disease
    Taylor, Fiona
    Huffman, Mark D.
    Macedo, Ana Filipa
    Moore, Theresa H. M.
    Burke, Margaret
    Smith, George Davey
    Ward, Kirsten
    Ebrahim, Shah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (01):
  • [29] Statins for Primary Prevention of Cardiovascular Disease
    Good, Chester B.
    Hernandez, Inmaculada
    Parekh, Natasha
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (01) : 72 - 72
  • [30] Statins for Primary Prevention of Cardiovascular Disease
    Lippi, Giuseppe
    Plebani, Mario
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (02) : 111 - 112